Antibacterial Activity of Eight Cephalosporins (Cefamandole Included) on Two Common Respiratory Pathogens (Haemophilus Influenzae and Diplococcus Pneumoniae)
Two hundred recent clinical isolates of Haemophilus and Pneumococcus were tested in vitro against eight cephalosporins by means of disc diffusion and agar dilution tests.
Cefamandole was the most active cephalosporin against Haemophilus, 97% of the strains being inhibited by 0,78 mcg per ml of this drug. In order of decreasing bacteriostatic effectiveness, the other drugs were classified as follows: cephapirin, cephalothin, cefoxitin, cephaloridine, cefazolin, cephradine and cephalexin. This, study suggest that prediction of the susceptibility of Haemophilus strains to cephalosporins, on the basis of one drug of this group testing alone, is likely to be hazardous.
The most active cephalosporins against D. pneumoniae were cephaloridine, cephapirine, cefazolin, cefamandole and cephalothin which inhibited 90% of the strains at 0,19 mcg per ml. Cefoxitin, cephradine and cephalexin were clearly less active, requiring 3,12mcg per ml to exhibit the same antibacterial activity. Nevertheless, none of the strains were clearly resistant to these drugs.
KeywordsMinimal Inhibitory Concentration Zone Diameter Neisseria Meningitidis Pneumococcus Strain Disk Agar Diffusion Method
Unable to display preview. Download preview PDF.
- 1.Bauer A.W., Kirby W.M.M., Sherris J.C. and Turck M.: Antibiotic susceptibility testing by a standardized single-disk method. Amer.J.CIin.Pathol. 45: 493–496 (1966).Google Scholar
- 4.May J.R.: The chemotherapy of chronic bronchitis and allied disorders. The English Universities Press Ltd, 1968.Google Scholar
- 5.Sabath L.D., Stumpf L.L., Wallace S.J. and Finland M.: Susceptibility of Diplococcus pneumoniae, Haemophilus influen’ae, and Neisseria meningitidis to 23 antibiotics. Antimicr.Ag.Chemother. 1970: 53–56.Google Scholar
- 6.Schiffer M.S., Mac Lowry J., Schneerson R., Robbins J.B.: Clinical, bacteriological and Immunological characterisation of ampicillin-resistant Haemophilus influenzae type B. Lancet,ii, 257–259 (1974).Google Scholar